focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,812.50
Bid: 1,700.00
Ask: 1,820.00
Change: 0.00 (0.00%)
Spread: 120.00 (7.059%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,812.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London open: UK stocks drop to five-month low ahead of CPI data

Tue, 16th Jun 2015 08:19

UK stocks dropped into the red for a third straight day on Tuesday on the back of ongoing concerns about Greece, a sell-off in China and caution ahead of inflation data.The FTSE 100 was trading 0.55% lower at 6,673.49 early on, after hitting a three-month closing low of 6,710.52 on Monday.The index has not finished below the 6,700 level since 20 January when it settled at 6,620.10.An abrupt end to debt talks on Sunday night in Brussels between Greece and its lenders has rattled investors' nerves over recent days, as discussions collapsed after just 45 minutes on the back of disagreements over issues such as pension reforms and tax rates.Meanwhile, stocks in Shanghai plunged again on Tuesday due to weakness in the financial sector as regulators tightened margin lending regulations and investors showed concerns and a new barrage of IPOs."The FTSE has already touched a five-month low this Tuesday, however briefly; yet the arrival of tangible news in the form of the UK's latest inflation figures later in the morning could provide some respite for the continually Eurozone-led index," said Spreadex analyst Connor Campbell.UK consumer price index (CPI) data due out at 09:30 is expected to show that prices bounced back in May after turning negative for the first time on record the month before. The annual rate of change in the CPI, the main measure of UK inflation, is predicted to show a 0.1% increase last month, according to the majority of analysts, following a 0.1% fall in April.UK producer price and retail price indices will also be released on Tuesday, along with an influx of data abroad, including building permits and housing starts in the States, the ZEW business sentiment index in Germany and new car registrations in Europe.Defensives gainA reduction in risk appetite benefitted stocks in defensive sectors such as tobacco and pharmaceuticals. British American Tobacco, Imperial Tobacco, AstraZeneca and Glaxosmithkline were all edging higher in London.GSK was also up on rumours it could become the latest takeover target in the industry. According to the Daily Mail, market participants are speculating that the company may face an approach from Switzerland's Roche or US company Johnson & Johnson at about 1900p per share.Mining stocks were among the worst performers, with Rio Tinto, Randgold and Antofagasta all in negative territory.Leisure group Whitbread fell despite saying it had started the new financial year well, as strong growth at its Costa and Premier Inn brands made up for weakness in the restaurants division.Industrial equipment hire company Ashtead underwhelmed with a 33% rise in full-year pre-tax profit to £473.8m on strong US and UK markets.Market MoverstechMARK 3,135.99 -0.49%FTSE 100 6,673.49 -0.55%FTSE 250 17,605.59 -0.69%FTSE 100 - RisersBritish American Tobacco (BATS) 3,452.00p +1.19%National Grid (NG.) 854.00p +0.64%GlaxoSmithKline (GSK) 1,358.00p +0.52%Imperial Tobacco Group (IMT) 3,186.00p +0.35%AstraZeneca (AZN) 4,151.50p +0.06%Tesco (TSCO) 214.10p +0.05%FTSE 100 - FallersInternational Consolidated Airlines Group SA (CDI) (IAG) 494.60p -2.73%Royal Mail (RMG) 492.60p -2.46%CRH (CRH) 1,791.00p -2.13%TUI AG Reg Shs (DI) (TUI) 1,150.00p -1.79%Antofagasta (ANTO) 715.50p -1.72%G4S (GFS) 276.60p -1.67%Randgold Resources Ltd. (RRS) 4,556.00p -1.51%Rio Tinto (RIO) 2,764.50p -1.50%easyJet (EZJ) 1,527.00p -1.48%Glencore (GLEN) 274.15p -1.47%FTSE 250 - RisersLadbrokes (LAD) 120.20p +2.73%CLS Holdings (CLI) 1,958.00p +2.03%Daejan Holdings (DJAN) 5,775.00p +1.67%NMC Health (NMC) 788.50p +1.09%Pets at Home Group (PETS) 276.50p +1.02%Jimmy Choo (CHOO) 159.30p +0.82%Rank Group (RNK) 219.10p +0.78%Virgin Money Holdings (UK) (VM.) 448.90p +0.76%JD Sports Fashion (JD.) 673.50p +0.75%Aberforth Smaller Companies Trust (ASL) 1,170.00p +0.52%FTSE 250 - FallersFoxtons Group (FOXT) 247.10p -2.95%Crest Nicholson Holdings (CRST) 529.50p -2.75%Lonmin (LMI) 126.20p -2.70%Evraz (EVR) 146.00p -2.67%Vesuvius (VSVS) 391.70p -2.61%Kaz Minerals (KAZ) 237.90p -2.50%Thomas Cook Group (TCG) 136.30p -2.43%Ophir Energy (OPHR) 119.00p -2.38%Allied Minds (ALM) 549.50p -2.14%Fidelity China Special Situations (FCSS) 165.00p -2.08%
More News
20 Dec 2023 13:29

GSK buys rights to Hansoh Pharma antibody-drug conjugate

(Sharecast News) - GSK has agreed to buy the rights to an antibody-drug conjugate (ADC) - HS-20093 - from Chinese biopharmaceutical group Hansoh Pharma.

Read more
19 Dec 2023 15:36

German court quashes CureVac patent after challenge by BioNTech

CureVac shares drop 40%Dispute over intellectual property with BioNTech to continue

*

Read more
18 Dec 2023 17:21

Energy stocks lift UK's FTSE 100, Vodafone shines

Vodafone jumps as Iliad offers to merge Italian units

*

Read more
18 Dec 2023 10:07

GSK's dostarlimab trial in endometrial cancer meets primary endpoint

(Alliance News) - GSK PLC on Monday said a trial of dostarlimab in combination with niraparib for treating endometrial cancer has met its primary endpoint.

Read more
18 Dec 2023 07:55

LONDON BRIEFING: Games Workshop seals Amazon deal for Warhammer 40,000

(Alliance News) - Stocks in London were set to retreat slightly on Monday, in line with equity markets in Asia, at the start of the last week before the Christmas holidays.

Read more
18 Dec 2023 07:18

GSK sees success in Jemperli endometrial cancer trial

(Sharecast News) - GSK released positive headline results from the planned analysis of its trial of Jemperli in endometrial cancer on Monday.

Read more
17 Dec 2023 15:16

PRESS: GSK looks for deals in China as rebuilds relationship

(Alliance News) - The Financial Times on Sunday reported that GSK PLC is looking for some new deals in China.

Read more
15 Dec 2023 17:08

European shares end fifth week higher on rate-cut optimism

Barclays sees first ECB rate cut in April

*

Read more
15 Dec 2023 16:51

LONDON MARKET CLOSE: FTSE 100 underperforms as post-Fed rally cools

(Alliance News) - London's FTSE 100 ended lower on Friday, with profit-taking and some hawkish words from a US policymaker keeping equities in check at the end of a largely positive week for stocks.

Read more
15 Dec 2023 16:29

PRESS: GSK, Astra and AbbVie in US scrutiny over patents - Bloomberg

(Alliance News) - A US senator has accused AstraZeneca PLC, GSK PLC, AbbVie Inc and other drugmakers of "abusing" the patent system to send prices higher, Bloomberg reported on Thursday.

Read more
12 Dec 2023 10:08

AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal

Dec 12 (Reuters) - AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion.

Read more
12 Dec 2023 08:22

TOP NEWS: Japan accepts GSK's filing for respiratory disease vaccine

(Alliance News) - GSK PLC on Tuesday said Japan's Ministry of Health, Labour & Welfare has accepted its regulatory application for the extension of its respiratory syncytial virus vaccine, Arexvy, for adults aged 50-59.

Read more
12 Dec 2023 07:39

LONDON BRIEFING: UK unemployment unchanged at 4.2%; eyes on US CPI

(Alliance News) - Stocks in London are called to open higher, as investors digest the latest UK unemployment data, before turning their heads to US inflation.

Read more
12 Dec 2023 07:24

GSK seeks to extend RSV vaccine approval in Japan

(Sharecast News) - GSK announced on Tuesday that Japan's Ministry of Health, Labour and Welfare (MHLW) has accepted its regulatory application for the extension of the indication of its RSV vaccine to include adults aged 50- to 59 at an increased risk of contracting the disease.

Read more
11 Dec 2023 08:28

GSK drug gets EU marketing backing for form of endometrial cancer

(Alliance News) - GSK PLC on Monday said it won EU backing for its Jemperli drug in tandem with chemotherapy to treat a form of endometrial cancer.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.